INS and serum lipopolysaccharide activity: Secondary outcomes included serum lipoprotein particle profiles, neutrophil NADPH oxidase activity, serum inflammatory markers Glyc-A and IL-6, biomarkers of endotoxemia, plasma glucose, and serum insulin and NEFA.